Top Banner
Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007) Nicholas Derrico
48

Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

Feb 04, 2016

Download

Documents

FINN

Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007). Nicholas Derrico. Background. Cancer causes 13% of all deaths worldwide. Background. Cancer causes 13% of all deaths worldwide Cancer has no cure. Background. - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

Synthesis of Biodegradable Nanospheres forSide-Effect-Free Anti-Cancer Drug Delivery

(2007)

Nicholas Derrico

Page 2: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

2

BackgroundBackground

• Cancer causes 13% of all deaths worldwide

Page 3: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

3

BackgroundBackground

• Cancer causes 13% of all deaths worldwide• Cancer has no cure

Page 4: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

4

BackgroundBackground

• Cancer causes 13% of all deaths worldwide• Cancer has no cure-all• Chemotherapy dissolves highly toxic drugs

into hydrophobic solutions, which are then administered to the patient, killing cells indiscriminately.

Page 5: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

5

Purpose

• To develop a cutting-edge, side-effect-free delivery system to encapsulate camptothecin in biodegradable, biocompatible nanospheres that will target only cancer cells

Page 6: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

6

Background

• Cancer cells have leaky vasculature

Page 7: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

7

Background

• Cancer cells have leaky vasculature

<200 nm

Page 8: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

8

Previous Studies

• Sheihet (2007) successfully encapsulated the drug paclitaxel

Page 9: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

9

Previous Studies

• Sheihet (2007) successfully encapsulated the drug paclitaxel

• Gounder (2007) used biodegradable, biocompatible nanospheres to kill cancer in mice without side-effects

Page 10: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

10

Goals

• To synthesize nanospheres from ABA-triblock copolymers that are < 200 nm in hydrodynamic diameter

Page 11: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

11

Goals

• To synthesize nanospheres from ABA-triblock copolymers that are < 200 nm in hydrodynamic diameter

• To determine the composition of ABA-triblock copolymers that will form nanospheres that can hold as much camptothecin as possible

Page 12: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

12

ABA-Triblock Copolymer

• Biodegradable

Page 13: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

13

ABA Triblock Copolymer

• Biodegradable

• Biocompatible

Page 14: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

14

ABA Triblock Copolymer

• Biodegradable

• Biocompatible

• Non-cytotoxic

Page 15: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

15

ABA Triblock Copolymer

• Biodegradable

• Biocompatible

• Non-cytotoxic

• Spontaneously self-assemble into nanospheres in aqueous solution

Page 16: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

16

B-Block

Page 17: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

17

Desaminotyrosyl Tyrosine Alkyl Ester

Page 18: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

18

Desaminotyrosyl Tyrosine Alkyl Ester

R = Pendant Chains

Page 19: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

19

Desaminotyrosyl Tyrosine Butyl Ester

Page 20: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

20

Desaminotyrosyl Tyrosine Octyl Ester

Page 21: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

21

Desaminotyrosyl Tyrosine Dodecyl Ester

Page 22: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

22

Desaminotyrosyl Tyrosine Benzyl Ester

Page 23: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

23

Desaminotyrosyl Tyrosine Alkyl Ester

Page 24: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

24

Suberic Acid

Page 25: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

25

B-Block

Page 26: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

26

Poly(ethylene glycol) = A-Block

Page 27: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

27

Self-Assembling into Nanospheres

B-Block

A-Block

Page 28: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

28

Self-Assembling into Nanospheres

Page 29: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

29

Self-Assembling into Nanospheres

Page 30: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

30

Self-Assembling into Nanospheres

=

Page 31: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

31

Self-Assembling into Nanospheres

Page 32: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

32

Self-Assembling into Nanospheres

Page 33: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

33

Self-Assembling into Nanospheres

Page 34: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

34

Self-Assembling into Nanospheres

Page 35: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

35

Page 36: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

36

Self-Assembling into Nanospheres

Page 37: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

37

CompositionsCopolymers Ratios

DTB-SA/5K 100%

DTO-SA/5K 100%

DTD-SA/5K 100%

DTBn-SA/5K 100%

DTB-SA/5K + DTO-SA/5K 50%-50%

DTB-SA/5K + DTD-SA/5K 50%-50%

DTB-SA/5K + DTBn-SA/5K 50%-50%

DTB-SA/5K + DTO-SA/5K

DTD-SA/5K + DTBn-SA/5K

25%-25%

25%-25%

Page 38: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

38

CompositionsCopolymers Ratios

DTB-SA/5K 100%

DTO-SA/5K 100%

DTD-SA/5K 100%

DTBn-SA/5K 100%

DTB-SA/5K + DTO-SA/5K 50%-50%

DTB-SA/5K + DTD-SA/5K 50%-50%

DTB-SA/5K + DTBn-SA/5K 50%-50%

DTB-SA/5K + DTO-SA/5K

DTD-SA/5K + DTBn-SA/5K

25%-25%

25%-25%

Page 39: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

39

Camptothecin Only Nanospheres

Results

Page 40: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

40

Camptothecin Only Nanospheres

Results

Page 41: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

41

0

10

20

30

40

50

60

70

1 to 1 1 to 3 1 to 6

CPT:VD3 Ratio wt/wt

VD3 Binding Efficiency

DTB-SA/5K

DTBn-SA/5K(DTB+DTBn)-SA/5K

Figure 5: VD3 Binding Efficiency of 3 best copolymer compositionsBinding Efficiencies of

Vitamin D3

Page 42: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

42

-8

-6

-4

-2

0

2

4

6

8

10

12

1 to 1 1 to 3 1 to 6

CPT:VD3 Ratio wt/wt

CPT Binding Efficiency

DTB-SA/5K

DTBn-SA/5K(DTB+DTBn)-SA/5K

Figure 4: CPT Binding Efficiency of 3 best copolymer compositionsBinding Efficiencies of

Camptothecin

Page 43: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

43

Conclusion

• 15% camptothecin was encapsulated

Page 44: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

44

Conclusion

• 15% camptothecin was encapsulated

• Pelleting occurred during ultracentrifugation

Page 45: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

45

Future Study

• Use ultrafiltration in procedure

Page 46: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

46

Acknowledgements

• Team Research

• Larisa Sheihet Ph.D

• Will Mallon

• Ms. Lois Fruen

QuickTime™ and aTIFF (Uncompressed) decompressorare needed to see this picture.

Page 47: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

47

Questions?

Page 48: Synthesis of Biodegradable Nanospheres for Side-Effect-Free Anti-Cancer Drug Delivery (2007)

Synthesis of Biodegradable Nanospheres forSide-Effect-Free Anti-Cancer Drug Delivery

(2007)

Nicholas Derrico